Tech Company Financing Transactions
Mitra Biotech Funding Round
Mitra Biotech, based in Woburn, secured $40 million from Northpond Ventures, Accel Partners and RA Capital.
Transaction Overview
Company Name
Announced On
7/13/2018
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Investors
Northpond Ventures (Lead Investor) (Michael Rubin)
Sands Capital Management (Ian Ratcliffe)
Proceeds Purpose
These funds will allow us to expand our commercial efforts, while also continuing to build the clinical evidence necessary to accelerate adoption and secure reimbursement in the U.S. and other key markets, said Mallikarjun Sundaram, President, Co-Founder, and CEO of Mitra.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12 Gill St. 3150
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Website
Email Address
Overview
Mitra Biotech is the global leader in therapy selection in oncology. Mitra is led by an accomplished team of diagnostic and drug development professionals and is backed by world leading venture groups with long term commitment to Mitra's vision in personalized cancer care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mallik Sundaram
Chief Medical Officer
Eric Rowinsky
Chief Scientific Officer
Pradip Majumder
Browse more venture capital transactions:
Prev: 7/13/2018: Workspot venture capital transaction
Next: 7/13/2018: Stronghold venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs